Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

M.P. EVANS GROUP PLC Regulatory Filings 2019

Jan 9, 2019

7798_rns_2019-01-09_e69e00d3-11db-4f2a-83f0-2798e58e7258.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5515M

M. P. Evans Group PLC

09 January 2019

M. P. EVANS GROUP PLC

("MPE" OR  "GROUP")

2018 crop and production

The Group is pleased to announce the following crop and production information for the year ended 31 December 2018:

2018 Increase/

(decrease)
2017
Tonnes % Tonnes
Crop of fresh fruit bunches (f.f.b.)
Own crop 573,000 32 434,500
Smallholder crop 149,600 48 101,300
Outside crop 106,500 (10) 118,300
829,100 27 654,100
Production*
Crude palm oil ("CPO") 192,500 25 154,000
Palm kernels ("PK") 43,500 30 33,500

*- figures include production from the Group's crop sold to third-party mills.

Enquiries:

M.P. Evans Group PLC                                                                   Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, Chairman

Tristan Price, Chief Executive

Matthew Coulson, Finance Director

Peel Hunt LLP  (Nomad and joint broker)                                Telephone: +44 (0) 20 7418 8900

Dan Webster

George Sellar

Guy Pengelley

finnCap    (Joint broker)                                                                Telephone: +44 (0) 20 7220 0500

Tim Redfern

Chris Raggett

Hudson Sandler   (Financial PR)                                                 Telephone: +44 (0) 20 7796 4133

Charlie Jack

Bertie Berger

Elfie Kent

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DRLSSFFMAFUSEIF